- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hologic readies mid-range 4500 scanner
Like other bone densitometry vendors, Hologic is enjoying a banneryear, thanks to momentum created by Merck's Fosamax drug for thetreatment of osteoporosis. In addition to overall market growth,Hologic, of Waltham, MA, claims to have increased its market
Like other bone densitometry vendors, Hologic is enjoying a banneryear, thanks to momentum created by Merck's Fosamax drug for thetreatment of osteoporosis. In addition to overall market growth,Hologic, of Waltham, MA, claims to have increased its market sharein the segment to around 58%, compared with about 45% a year ago.
Hologic will try to build on its success by introducing a newmid-range member of its 4500 dual-energy x-ray absorptiometryfamily of bone measurement devices, according to Wade Fox, directorof marketing. Hologic developed the new system based on feedbackfrom clinicians, Fox said.
Hologic will also show its Sahara waterless ultrasound densitometer,which is not yet available in the U.S., as well as the mini C-armproduct line the company acquired through its purchase of Fluoroscanin August, Fox said.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
